USPTO serial 76333310
RAPID-X
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- LAMOTHE, LESLEY
- Law office
- DIVISIONAL UNIT
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with RAPID-X?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Glenn A. Gundersen
GLENN A GUNDERSEN DECHERT4000 BELL ATLANTIC TWR1717 ARCH STPHILADELPHIA, PA 19103-2793Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 007 | Manufacturing equipment, namely, machines used in researching, developing and manufacturing pharmaceuticals, nutraceuticals, chemicals, proteins, peptides, oligonucleotides, DNA, vaccines, other biotechnology-derived products, and other products using supercritical fluid technology | ACTIVE | — |
| 009 | Laboratory equipment for use in researching, developing and manufacturing pharmaceuticals, nutraceuticals, chemicals, proteins, peptides, oligonucleotides, DNA, vaccines, other biotechnology-derived products, and other products using supercritical fluid technology | ACTIVE | — |
| 040 | Custom manufacturing of pharmaceuticals, nutraceuticals, chemicals, proteins, peptides, oligonucleotides, DNA, vaccines, other biotechnology-derived products, and other products using supercritical fluid technology | ACTIVE | — |
| 042 | Conducting feasibility studies for others on the use of supercritical fluids in the formulation of pharmaceuticals, nutraceuticals, chemicals, proteins, peptides, oligonucleotides, DNA, vaccines, other biotechnology-derived products, and other products; licensing of intellectual property namely, licensing of supercritical fluid technology; developing pharmaceuticals, nutraceuticals, chemicals, proteins, peptides, oligonucleotides, DNA, vaccines, other biotechnology-derived products, and other products for others using supercritical fluid technology | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by LAVIPHARM LABORATORIES INC.
- Other trademarks owned by LAVIPHARM LABORATORIES INC.
- Other trademarks in Class 007
- Other trademarks in Class 009
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named RAPID-X
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 27, 2005 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Sep 27, 2005 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Sep 30, 2004 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Sep 15, 2004 | EXT1 | SOU EXTENSION 1 FILED | — |
| Sep 15, 2004 | PAPER RECEIVED | — | |
| Jun 23, 2004 | CFIT | CASE FILE IN TICRS | — |
| Apr 6, 2004 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 16, 2003 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Sep 9, 2003 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 20, 2003 | NPUB | NOTICE OF PUBLICATION | — |
| Jul 26, 2003 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 21, 2003 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Jun 17, 2003 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Apr 24, 2003 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 21, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 21, 2003 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Apr 21, 2003 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Apr 17, 2003 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 16, 2002 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 3, 2002 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 13, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 13, 2002 | PAPER RECEIVED | — | |
| Aug 12, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 11, 2002 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 29, 2002 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 25, 2002 | DOCK | ASSIGNED TO EXAMINER | — |